Extended Data Table 6 Manufactured Descartes-08 dose

From: BCMA-directed mRNA CAR T cell therapy for myasthenia gravis: a randomized, double-blind, placebo-controlled phase 2b trial

  1. MGC, Myasthenia Gravis Composite; mITT, modified intention-to-treat; SD, standard deviation.
Back to article page